Bing Li

Prof. Dr. Bing Li


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Cancer
Verified
Journal Article
Open access
QPQiufeng Pan
Qiufeng Pan
LWLongwang Wang
Longwang Wang
SCShuaishuai Chai
Shuaishuai Chai
HZHao Zhang
Hao Zhang
BLBing Li
Bing Li
The tumor immune microenvironment in clear cell Renal Cell Carcinoma (ccRCC) still remains poorly understood. Previous methods to study the tumor immune microenvironment have a limitation when accounting for the functionally distinct cell types. In this study, we investigated the differently infiltrated immune cells and their clinical significance in ccRCC for the purpose of shedding some important light on the complex immune microenvironment in ccRCC. The devolution algorithm (CIBERSORT) was applied to infer the proportion of 22 immune infiltrating cells based on gene expression profiles of ccRCC bulk tissue, which were downloaded from TCGA and GEO databases. As a result, we observed considerable differences in immune cells percentage between ccRCC tumor tissue and paired normal tissue; meanwhile, we uncovered their internal correlations and associations with Fuhrman grade. Moreover, dendritic cells resting, dendritic cells activated, mast cells resting, mast cells activated and eosinophils were associated with favorable prognosis, whereas B cells memory, T cells follicular helper and T cells regulatory (Tregs) were correlated with poorer outcome.

23 May 2022 in European Urology
Verified
Journal Article
Open access
CLChaoqi Liang
Chaoqi Liang
JWJianli Wang
Jianli Wang
BHBo Hai
Bo Hai
YXYujie Xu
Yujie Xu
JZJinmin Zeng
Jinmin Zeng
BLBing Li
Bing Li
Management of a long proximal ureteral stricture is challenging. Lingual mucosal graft ureteroplasty (LMGU) is a novel minimally invasive technique for ureteral reconstruction that avoids the morbidity of bowel interposition or autotransplantation. To evaluate the long-term effectiveness of LMGU for managing long, complex proximal ureteral strictures in a multi-institutional cohort of patients. This retrospective study involved data for 41 patients treated with LMGU at three centers between June 2015 and January 2021. LMGU was performed using either an onlay ureteroplasty in which the diseased ureter was incised ventrally and repaired with a lingual mucosal graft (LMG) to widen the ureteral lumen, or an augmented anastomotic technique in which the obliterated segment of the ureter was excised and reanastomosed primarily on dorsal side, and an LMG was placed on the ventral side. Pre-, intra-, and postoperative variables and outcomes were assessed. A descriptive statistical analysis was performed. Of 41patients, 40 were operated with laparoscopic procedures and one with a robot. Twenty-four (59%) patients underwent an onlay ureteroplasty, and 17 (41%) underwent an augmented anastomotic ureteroplasty. The reconstructed ureter was wrapped with omentum in 90% of cases. The median (range) stricture length was 4.8 cm (2.0-8.0), operative time was 166 min (98-306), and estimated blood loss was 65 ml (15-220). No open conversions and intraoperative complications occurred. At a median follow-up of 35 mo (range 13-80), the overall success rate was 97.6% (40/41). LMGU is a safe, feasible, and effective long-term technique for managing long, complex proximal ureteral strictures. We reported a novel technique for long proximal complex ureteral strictures using an onlay lingual mucosal graft (LMG). Our 6-yr outcomes demonstrate that onlay LMG ureteroplasty is a safe, feasible, and effective long-term procedure for ureteral reconstruction.

26 April 2016 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
BLBing Li
Bing Li
YXYujie Xu
Yujie Xu
BHBo Hai
Bo Hai
BLBing Liu
Bing Liu
YXYechen Xiang
Yechen Xiang
THTeng Hou
Teng Hou

13 June 2019 in Medical Science Monitor
Verified
Journal Article
Closed access
PDF file
QPQiufeng Pan
Qiufeng Pan
LWLongwang Wang
Longwang Wang
HZHao Zhang
Hao Zhang
CLChaoqi Liang
Chaoqi Liang
BLBing Li
Bing Li
BACKGROUND:Although the mortality rates of clear cell renal cell carcinoma (ccRCC) have decreased in recent years, the clinical outcome remains highly dependent on the individual patient. Therefore, identifying novel biomarkers for ccRCC patients is ...

10 April 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
YCYande Cui
Yande Cui
JHJianhua Hu
Jianhua Hu
ZDZiyang Dong
Ziyang Dong
BLBing Li
Bing Li
Chunyu  ChangChunyu Chang
Chunyu Chang
Pneumatic artificial muscles have been widely used in the field of robotics because of their large output force and fast actuation, however, the accompanying bulky compressors and pumps limit their miniaturized applications. Despite current untethered pneumatic artificial muscles can be driven by adjusting the internal pressure, it is challenging to structurally mimic natural muscles with high water content. Here, we propose untethered pneumatic artificial muscles comprising a hydrogel actuator with snap-through instability and an air storage chamber. These hydrogel actuators can realize the conversion from hydrophobic association of octyl acrylate moieties to host-guest interaction between β-cyclodextrin and octyl acrylate under thermal stimuli, leading to the decrease of their moduli. The inflated hydrogel actuators exhibit rapid actuation with a radial expansion speed of 200% s−1, which are powered by snap-through instability, thermal expansion of the gas inside the hydrogel actuator, and evaporation of water on its internal surface. With the pneumatic artificial muscles miniaturized, we demonstrate diving and rolling robots, exemplifying bionic robots able to adapt to and modify the environment. We expect that the design of hydrogel actuator in miniaturized pneumatic artificial muscles will facilitate rapid locomotion for future bionic robotic platforms.

19 February 2020 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
QPQiufeng Pan
Qiufeng Pan
GCGong Cheng
Gong Cheng
YLYuenan Liu
Yuenan Liu
TXTianbo Xu
Tianbo Xu
HZHao Zhang
Hao Zhang
BLBing Li
Bing Li
Clear cell renal cell carcinoma (ccRCC) is one of the most common urological malignancies. Identifying novel biomarkers and investigating the underlying mechanism of ccRCC development will be crucial to the management and treatment of ccRCC in patients. Thymosin b10 (TMSB10), a member of the thymosin family, is involved in various physiological processes, including tissue regeneration and inflammatory regulation. Moreover, it has been found to be upregulated in many types of carcinoma. However, its roles in ccRCC remain to be elucidated. The present study aimed to explore the expression of TMSB10 in ccRCC through mining The Cancer Genome Atlas (TCGA) and Oncomine databases, and to investigate the association between TMSB10 expression and clinicopathological factors. Furthermore, immunohistochemistry assays and western blotting were conducted to verify TMSB10 expression levels in human ccRCC tissues and cell lines. Functional analyses were also performed to identify the roles of TMSB10 in vitro. The results revealed that TMSB10 was significantly upregulated in RCC tissues and cell lines. The expression of TMSB10 was closely associated with various clinicopathological parameters. In addition, high expression of TMSB10 predicted poor clinical outcome. The receiver operating characteristic curve revealed that TMSB10 could sufficiently distinguish the tumor from normal kidney (area under the curve = 0.9543, P<0.0001). Furthermore, knockdown of TMSB10 impaired the proliferation of ccRCC cells, and attenuated cell and invasion in vitro. In addition, TMSB10 knockdown downregulated reduced the phosphorylation of PI3K and the expression of vascular endothelial growth factor. In conclusion, the present study demonstrated that high expression of TMSB10 could serve as a useful diagnostic and prognostic biomarker and a potential therapeutic target for ccRCC.